Moderna Starts Phase 1 Trial of Experimental Ebola Vaccine for Congo Outbreak

Moderna Inc. has begun testing an experimental Ebola vaccine in people, marking the second candidate to enter clinical trials against the strain driving the deadliest Ebola outbreak in Democratic Republic of Congo’s history.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.